Telara Pharma - focused and committed to kidney disease improvement.

focused and committed to kidney disease improvement.

Home
Science
Pipeline
About Us
News

Research Style 1

Telara Pharma > Research Style 1

Research Style 1

Telara Pharma is a global leader in repurposing the drug cilastatin to make new therapies for severe inflammatory disorders like Acute Kidney Injury (AKI).

Menu

Home
Pipeline
About Us
News
Contact

SCIENCE

Problem
Solution
Specific Data
Papers

RECENT POST

Our CSO Dr. Alberto Lázaro publishes a Commentary in the Kidney International Journal about Cilastatin September 23, 2024
Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins August 2, 2024

Copyright © 2024 TelaraPharma. All rights reserved.